| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,§,§
*
Departments of Biology, Microbiology-Immunology, and Obstetrics and Gynecology and
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599; and
Department of Pharmacology and
§
Cancer Research Institute, Kanazawa University, Kanazawa, Japan
Paclitaxel is a frontline therapy for ovarian cancer. Our laboratory has shown that paclitaxel induces IL-8, a member of the C-X-C family of chemokines, in subsets of human ovarian cancer cells. However, the critical issue concerns the biological significance of this chemokine in human ovarian cancer. To study the influence of IL-8 on tumor growth, human ovarian cancer cell lines were transfected with an expression vector for human IL-8 and tested for their ability to form tumors in nude mice. IL-8 expression by the transfected cells did not alter their growth properties in vitro. In contrast, tumor growth in vivo was significantly attenuated in animals receiving IL-8-expressing cells when compared with mice injected with control cells. As additional evidence that IL-8 is a crucial factor in tumor growth, it was noted that ovarian cell lines in which constitutive IL-8 expression is elevated did not form tumors. Injection of neutralizing Ab to IL-8 reverted the phenotype and caused tumor growth in vivo. Examination of tissue from the inoculation site revealed a dramatically elevated cellularity, containing neutrophils and macrophages, in mice receiving IL-8-expressing tumor cells. These results suggest that IL-8 production by human ovarian tumor cells can play a role in reducing the rate of tumor growth; this effect may be mediated by the increased targeting of neutrophil and other mononuclear cells to the tumor injection site. These studies indicate a role for IL-8 in ovarian cancer control and suggest that chemotherapy-induced IL-8 may have a positive role in controlling tumor growth.
This article has been cited by other articles:
|
|
 |
|
  S. R. Perri, D. Martineau, M. Francois, L. Lejeune, L. Bisson, Y. Durocher, and J. Galipeau Plasminogen Kringle 5 blocks tumor progression by antiangiogenic and proinflammatory pathways Mol. Cancer Ther., February 1, 2007; 6(2): 441 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. De Larco, B. R. K. Wuertz, and L. T. Furcht The Potential Role of Neutrophils in Promoting the Metastatic Phenotype of Tumors Releasing Interleukin-8 Clin. Cancer Res., August 1, 2004; 10(15): 4895 - 4900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Mukaida Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases Am J Physiol Lung Cell Mol Physiol, April 1, 2003; 284(4): L566 - L577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Hu, J. Hofmann, C. Zaloudek, N. Ferrara, T. Hamilton, and R. B. Jaffe Vascular Endothelial Growth Factor Immunoneutralization Plus Paclitaxel Markedly Reduces Tumor Burden and Ascites in Athymic Mouse Model of Ovarian Cancer Am. J. Pathol., November 1, 2002; 161(5): 1917 - 1924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Salcedo, M. Martins-Green, B. Gertz, J. J. Oppenheim, and W. J. Murphy Combined Administration of Antibodies to Human Interleukin 8 and Epidermal Growth Factor Receptor Results in Increased Antimetastatic Effects on Human Breast Carcinoma Xenografts Clin. Cancer Res., August 1, 2002; 8(8): 2655 - 2665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kawakami, M. Kawakami, P. J. Snoy, S. R. Husain, and R. K. Puri In Vivo Overexpression of IL-13 Receptor {alpha}2 Chain Inhibits Tumorigenicity of Human Breast and Pancreatic Tumors in Immunodeficient Mice J. Exp. Med., December 17, 2001; 194(12): 1743 - 1754. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Cairns, J. R. Gordon, F. Li, M. E. Baca-Estrada, T. Moyana, and J. Xiang Lymphotactin Expression by Engineered Myeloma Cells Drives Tumor Regression: Mediation by CD4+ and CD8+ T Cells and Neutrophils Expressing XCR1 Receptor J. Immunol., July 1, 2001; 167(1): 57 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhang, S. Wei, J. Sun, D. Coppola, B. Zhong, G. D. Wu, B. Goodwin, S. Sebti, J. Y. Djeu, and G. Blanck Retinoblastoma Protein Activation of Interleukin 8 Expression Inhibits Tumor Cell Survival in Nude Mice Cell Growth Differ., December 1, 2000; 11(12): 635 - 639. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Huang, J. B. Robinson, A. DeGuzman, C. D. Bucana, and I. J. Fidler Blockade of Nuclear Factor-{{kappa}}B Signaling Inhibits Angiogenesis and Tumorigenicity of Human Ovarian Cancer Cells by Suppressing Expression of Vascular Endothelial Growth Factor and Interleukin 8 Cancer Res., October 1, 2000; 60(19): 5334 - 5339. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
